Anthrax: Diagnosis, treatment, prevention

Primary Care Update for Ob/Gyns

Volumn 9, Issue 4, 2002, Pages 117-121

  Jamie, Whitney E ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; PENICILLIN G; PENICILLIN V; STREPTOMYCIN;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL ENDOSPORE; BACTERIUM CULTURE; BIOLOGICAL WARFARE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DEATH; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM STAINING; HIGH RISK POPULATION; HUMAN; INOCULATION; INTENSIVE CARE UNIT; MEDIASTINUM LYMPH NODE; MORBIDITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VACCINATION;

EID: 0036310859     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(02)00100-2     Document Type: Article

References (10)

1. Review. Inhalational anthrax. Epidemiology, diagnosis, and management
2. Anthrax. Medical progress. Review article
3. Recognition and management of anthrax - An update. Current concepts
4. Anthrax as a biological weapon: Medical and public health management
5. The Sverdlovsk anthrax outbreak of 1979
6. Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices. CDC
7. Field evaluation of a human anthrax vaccine
8. CDC update: Update on emerging infections from the Centers for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines from management - United States, 1998